Suppression of intestinal polyposis in Apc(Δ716) knockout mice by inhibition of cyclooxygenase 2 (COX-2)

Cell

Volumn 87, Issue 5, 1996, Pages 803-809

  Oshima, Masanobu ^a   Dinchuk, Joseph E ^b   Kargman, Stacia L ^c   Oshima, Hiroko ^a   Hancock, Bruno ^c   Kwong, Elizabeth ^c   Trzaskos, James M ^b   Evans, Jilly F ^c   Taketo, Makoto M ^a,d  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

^b DUPONT COMPANY   (United States)

^c MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN SYNTHASE; SULINDAC;

ARTICLE; CARCINOGENESIS; COLORECTAL CANCER; ENZYME ACTIVITY; ENZYME INHIBITION; GASTROINTESTINAL POLYPOSIS; GENE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

EID: 0030606299     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81988-1     Document Type: Article

References (39)

1. Boolbol, S.K., Dannenberg, A.J., Chadburn, A., Martucci, C., Guo, X.J., Ramonetti, J.T., Abreu-Goris, M., Newmark, H.L., Lipkin, M.L., DeCosse, J.J., and Bertagnolli, M.M. (1996). Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res. 56, 2556-2560.
2. Boynton, R.F. Blount, P.L., Yin, J., Brown, V.L., Huang, Y., Tong, Y., McDaniel, T., Newkirk, C., Resau, J.H., Raskind, W.H., et al. (1992). Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc. Natl. Acad. Sci. USA 89, 3385-3388.
3. DeWitt, D.L. and Smith, W.L. (1988). Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc. Natl. Acad. Sci. USA 85, 1412-1416.
4. Dietrich, W.F., Lander, E.S., Smith, J.S., Moser, A.R., Gould, D.A., Luongo, C., Borenstein, N., and Dove, W. (1993). Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75, 631-639.
5. Dinchuk, J.E., Car, B.D., Focht, R.J., Johnston, J.J., Jaffee, B. D., Covington, M.B., Contel, N.R., Eng, V.M., Collins, R.J., Czerniak, P.M., et al. (1995). Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378, 406-409.
6. DuBois, R.N., Radhika, A., Reddy, B.S., and Entingh, A.J. (1996). Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterol. 110, 1259-1262.
7. DuBois, R.N., Awad, J., Morrow, J., Roberts, L.J., and Bishop, P.R. (1994). Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-α and phorbol ester. J. Clin. Invest. 93, 493-496.
8. Eberhart, G.E., Coffey, R.J., Radhika, A., Giardiello, F.M., Ferrenbach, S., and DuBois, R.N. (1994). Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterol. 107, 1183-1188.
9. Giardiello, F.M., Hamilton, S.R., Krush, A.J., Piantadosi, S., Hylind, L.M., Celano, P., Booker, S.V., Robinson, C.R., and Offerhaus, G.J.A. (1993). Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. New Engl. J. Med. 328, 1313-1316.
10. Hemler, M., and Lands, W.E.M. (1976). Purification of the cyclooxygenase that forms prostaglandins. J. Biol. Chem. 251, 5575-5579.
11. Horii, A., Nakatsuru, S., Miyoshi, Y., Ichii, S., Nagase, H., Kato, Y., Yanagisawa, A., and Nakamura, Y. (1992). The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res. 52, 3231-3233.
12. Kargman, S.L., O'Neill, G.P., Vickers, P.J., Evans, J.F., Mancini, J.A., and Jothy, S. (1995). Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 55, 2556-2559.
13. Kargman, S., Wong, E., Greig, G.M., Falgueyret, J.-P., Cromlish, W., Ethier, D., Yergey, J.A., Riendeau, D., Evans, J.F., Kennedy, B., et al. (1996). Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cells. Biochem. Pharmacol., in press.
14. Laird, P.W., Jackson-Grusby, L., Faseli, A., Dickinson, S.L., Jung, W.E., Li, E., Weinberg, R.A., and Jaenisch, R. (1995). Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81, 197-205.
15. Lee, S.H., Soyoola, E., Chanmugam, P., Hart, S., Sun, W., Zhong, H., Liou, S., Simmons, D., and Hwang, D. (1992). Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267, 25934-25938.
16. Li, E., Bestor, T.H., and Jaenisch, R., (1992). Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915-926.
17. Min-induced intestinal neoplasia. Cell 81, 957-966.
18. Maier, J.A.M., Hla, T. and Maciag, H. (1990). Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J. Biol. Chem. 265, 10805-10808.
19. Marnett, L.J. (1992). Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 52, 5575-5589.
20. Meade, E.A., Smith, W.L., and DeWitt, D.L. (1993). Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal antiinflammatory drugs. J. Biol. Chem. 268, 6610-6614.
21. Mitchell, J.A., Akarasereenont, P., Thiemermann, C., Flower, R.J., and Vane, J.R. (1994). Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA 90, 11693-11697.
22. Miyamoto, T., Ogino, N., Yamamoto, S., and Hayaishi, O. (1976). Purification of prostaglandin endoperoxide synthase from bovine vesicular gland microsomes. J. Biol. Chem. 251, 2629-2636.
23. Morham, S.G., Langenbach, R., Loftin, C.D., Tiano, H.F., Vouloumanos, N., Jennette, J.C., Mahler, J.F., Kluckman, K.D., Ledford, A., Lee, C. A., and Smithies, O. (1995). Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83, 473-482.
24. Moser, A.R., Pitot, H.C., and Dove, W.F. (1990). A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247, 322-324.
25. O'Banion, M.K., Winn, V.D., and Young, D.A. (1992). cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. Natl. Acad. Sci. USA 89, 4888-4892.
26. O'Neill, G.P., and Ford-Hutchinson, A.W. (1993). Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 330, 156-160.
27. Oshima, M., Oshima, H., Kitagawa, K., Kobayashi, M., Itakura, C., and Taketo, M. (1995a). Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. USA 92, 4482-4486.
28. Δ716 knockout mice. Carcinogenesis 16, 2605-2607.
29. Δ716 knockout mice. Mol. Carcinogen. 15, 11-17.
30. Powell, S.M., Zilz, N., Beazer-Barclay, Y., Bryan, T.M., Hamilton, S.R., Thibodeau, S.N., Vogelstein, B., and Kinzler, K.W. (1992). APC mutations occur early during colorectal tumorigenesis. Nature 359, 235-237.
31. Rao, C.V., Rivernson, A., Simi, B., Zang, E., Kelloff, G., Steele, V., and Reddy, B.S. (1995). Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res. 55, 1464-1472.
32. Reddy, B.S., Rao, C.V., Rivenson, A., and Kelloff, G. (1993). Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 14, 1493-1497.
33. Rigas, B., Goldman, I.S., and Levine, L. (1993). Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med. 122, 518-523.
34. Su, L.K., Kinzler, K.W., Vogelstein, B., Preisinger, A.C., Moser, A.R., Luongo, C., Gould, K.A., and Dove, W.F. (1992). Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 250, 668-670.
35. Tsujii, M., and DuBois, R.N. (1995). Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83, 493-501.
36. Vane, J.R. (1971). Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol. 231, 232-235.
37. Vane, J. (1994). Towards a better aspirin. Nature 367, 215-216.
38. Williams, C.W., Luongo, C., Radhika, A., Zhang, T., Lamps, L.W., Nanney, L.B., Beauchamp, R.D., and DuBois, R.N. (1996). Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterol. 110, 1134-1140.
39. Xie, W., Robertson, D.L., and Simmons, D.L. (1992). Mitogen-inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs. Drug Dev. Res. 25, 249-265.